Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
24 August 2015 |
Main ID: |
NCT02523001 |
Date of registration:
|
10/08/2015 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Effect of Statin Treatment on Urinary AQP2 (uAQP2/01)
uAQP2/01 |
Scientific title:
|
Urinary AQP2 Excretion in Hypercholesterolemic Patients as a Measure of Effect of Statin Therapy |
Date of first enrolment:
|
October 2013 |
Target sample size:
|
37 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02523001 |
Study type:
|
Observational |
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Italy
| | | | | | | |
Contacts
|
Name:
|
Piero Portincasa |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
University of Bari Medical School |
| | |
Key inclusion & exclusion criteria
|
Inclusion criteria:
- patients on primary prevention requiring moderate reduction of LDL-cholesterol
according to the ACC/AHA Guidelines
- age 40 to 75 years
- estimated 10-year ASCVD risk =7.5%
Exclusion criteria:
- concomitant type 1 or type 2 diabetes
- blood hypertension
- concomitant use of diuretics or other drugs interfering with simvastatin
Age minimum:
40 Years
Age maximum:
75 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Diabetes Insipidus
|
Hypercholesterolemia
|
Primary Outcome(s)
|
uAQP2
[Time Frame: 0, 1, 4, 12 weeks]
|
Secondary Outcome(s)
|
Cholesterolemia
[Time Frame: 0, 1, 4, 12 weeks]
|
Secondary ID(s)
|
MRAR08P011
|
uAQP2/01
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|